Soluble tumour necrosis factor receptors in synovial fluids from temporomandibular joints with painful anterior disc displacement without reduction and osteoarthritis

Archives of Oral Biology

Volumn 49, Issue 2, 2004, Pages 133-142

  Uehara, Junji ^a   Kuboki, Takuo ^a   Fujisawa, Takuo ^a   Kojima, Shunji ^a   Maekawa, Kenji ^a   Yatani, Hirofumi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Osteoarthritis (OA); Soluble form receptor; Synovial fluid; Temporomandibular joint (TMJ); TNF

Indexed keywords

EID: 0742288637     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archoralbio.2003.07.001     Document Type: Article

References (37)

1. Ali A.M., Sharawy M.M. Histopathological changes in rabbit craniomandibular joint associated with experimentally induced anterior disk displacement (ADD). J. Oral Pathol. Med. 23:1994;364-374.
2. Stegenga B. Osteoarthritis of the temporomandibular joint organ and its relationship to disc displacement. J. Orofac. Pain. 15:2001;193-205.
3. Aggarwal B.B., Natarajan K. Tumour necrosis factors: developments during the last decade. Eur. Cytokine Netw. 7:1996;93-124.
4. Saklatvala J. Tumour necrosis factor alpha stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature. 322:1986;547-549.
5. Campbell I.K., Piccoli D.S., Roberts M.J., Muirden K.D., Hamilton J.A. Effects of tumor necrosis factor alpha and beta on resorption of human articular cartilage and production of plasminogen activator by human articular chondrocytes. Arthritis Rheum. 33:1990;542-552.
6. Mitchell P.G., Cheung H.S. Tumour necrosis factor alpha and epidermal growth factor regulation of collagenase and stromelysin in adult porcine articular chondrocytes. J. Cell. Physiol. 149:1991;132-140.
7. Arend W.P., Dayer J.M. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum. 33:1990;305-315.
8. Westacott C.I., Whicher J.T., Barnes I.C., Thompson D., Swan A.J., Dieppe P.A. Synovial fluid concentration of five different cytokines in rheumatic diseases. Ann. Rheum. Dis. 49:1990;676-681.
9. Di Giovine F.S., Nuki G., Duff G.W. Tumour necrosis factor in synovial exudates. Ann. Rheum. Dis. 47:1988;768-772.
10. Takahashi T., Kondoh T., Fukuda M., Yamazaki Y., Toyosaki T., Suzuki R. Proinflammatory cytokines detectable in synovial fluids from patients with temporomandibular disorders. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 85:1998;135-141.
11. Nordahl S., Alstergren P., Kopp S. Tumour necrosis factor-alpha in synovial fluid and plasma from patients with chronic connective tissue disease and its relation to temporomandibular joint pain. J. Oral Maxillofac. Surg. 58:2000;525-530.
12. Fu K., Ma X., Zhang Z., Chen W. Tumour necrosis factor in synovial fluid of patients with temporomandibular disorders. J. Oral Maxillofac. Surg. 53:1995;424-426.
13. Bazzoni F., Beutler B. The tumor necrosis factor ligand and receptor families. N. Engl. J. Med. 334:1996;1717-1725.
14. Porteu F., Brockhaus M., Wallach D., Engelmann H., Nathan C.F. Human neutrophil elastase releases a ligand-binding fragment from the 75-kDa tumor necrosis factor (TNF) receptor: comparison with the proteolytic activity responsible for shedding of TNF receptors from stimulated neutrophils. J. Biol. Chem. 266:1991;18846-18853.
15. Ohe H., Takashiba S., Naruishi K.et al. Tumour necrosis factor-alpha (TNF-alpha)-induced and interleukin-1 beta (IL-1 beta)-induced shedding of TNF receptors from gingival fibroblasts. J. Interferon Cytokine Res. 20:2000;1077-1082.
16. Arend W.P., Dayer J.M. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis Rheum. 38:1995;151-160.
17. Camussi G., Lupia E. The future role of anti-tumour necrosis factor (TNF) products in the treatment of rheumatoid arthritis. Drugs. 55:1998;613-620.
18. Alaaeddine N., DiBattista J.A., Pelletier J.P.et al. Osteoarthritic synovial fibroblasts possess an increased level of tumor necrosis factor-receptor 55 (TNF-R55) that mediates biological activation by TNF-alpha. J. Rheumatol. 24:1997;1985-1994.
19. Rooney M., Varsani H., Martin K., Lombard P.R., Dayer J.M., Woo P. Tumour necrosis factor alpha and its soluble receptors in juvenile chronic arthritis. Rheumatology (Oxford). 39:2000;432-438.
20. Pisetsky D.S. Tumour necrosis factor blockers in rheumatoid arthritis. N. Engl. J. Med. 342:2000;810-811.
21. Andreas M.R. New indications for treatment of chronic inflammation by TNF-blockade. Am. J. Med. Sci. 325:2003;75-92.
22. Kanyama M., Kuboki T., Kojima S.et al. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis. J. Orofac. Pain. 14:2000;20-30.
23. Orsini M.G., Kuboki T., Terada S., Matsuka Y., Yatani H., Yamashita A. Clinical predictability of temporomandibular joint disc displacement. J. Dent. Res. 78:1999;650-660.
24. Matsuka Y., Itoh S., Minakuchi H., Kuboki T., Yamashita A. Validity of questionnaire for epidemiological studies on symptoms of temporomandibular disorders. J. Jpn. Soc. TMJ. 9:1997;80-91.
25. Shafer D.M., Assael L., White L.B., Rossomando E.F. Tumour necrosis factor-alpha as a biochemical marker of pain and outcome in temporomandibular joints with internal derangements. J. Oral Maxillofac. Surg. 52:1994;786-791.
26. Emshoff R., Puffer P., Rudisch A., Gassner R. Temporomandibular joint pain: relationship to internal derangement type, osteoarthrosis, and synovial fluid mediator level of tumor necrosis factor-alpha. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 90:2000;442-449.
27. Sandler N.A., Buckley M.J., Cillo J.E., Braun T.W. Correlation of inflammatory cytokines with arthroscopic findings in patients with temporomandibular join internal derangements. J. Oral Maxillofac. Surg. 56:1998;534-543.
28. Segami N., Miyamaru M., Nishimura M., Suzuki T., Kaneyama K., Murakami K. Does joint effusion on T2 magnetic resonance images reflect synovitis? Part 2. Comparison of concentration levels of proinflammatory cytokines and total protein in synovial fluid of the temporomandibular joint with internal derangements and osteoarthrosis. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 94:2002;515-521.
29. Kaneyama K., Segami N., Nishimura M., Suzuki T., Sato J. Importance of proinflammatory cytokines in synovial fluid from 121 joints with temporomandibular disorders. Br. J. Oral Maxillofac. Surg. 40:2002;418-423.
30. Girardin E., Roux-Lombard P., Grau G.E.et al. Imbalance between tumor necrosis factor-alpha and soluble TNF receptor concentrations in severe meningococcaemia. Immunology. 76:1992;20-23.
31. Van Zee K.J., Kohno T., Fischer E., Rock C.S., Moldawer L.L., Lowry S.F. Tumour necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 89:1992;4845-4849.
32. Feldmann M. What is the mechanism of action of anti-tumour necrosis factor-alpha antibody in rheumatoid arthritis? Int. Arch. Allergy Immunol. 111:1996;362-365.
33. Alsalameh S., Mattka B., Al-Ward R. Preferential expression of tumor necrosis factor receptor 55 (TNF-R55) on human articular chondrocytes: selective transcriptional upregulation of TNF-R75 by proinflammatory cytokines interleukin 1beta, tumor necrosis factor-alpha, and basis fibroblast growth factor. J. Rheumatol. 26:1999;645-653.
34. Prieur A.R.M., Oux-Lombard P., Dayer J.M. Dynamics of fever and the cytokine network in systemic juvenile arthritis. Rev. Rhum. Engl. Ed. 63:1996;163-170.
35. Kuboki T., Hattori T., Mizushima T.et al. Detection of specific antibodies against human cultured chondrosarcoma (HCS-2/8) and osteosarcoma (Saos-2) cells in the serum of patients with osteoarthritis of the temporomandibular joint. Arch. Oral Biol. 44:1999;403-414.
36. Garrison L., McDonnell N.D. Etanercept: therapeutic use in patients with rheumatoid arthritis. Ann. Rheum. Dis. 58:1999;165-169.
37. Kacena M.A., Merrel G.A., Konda S.R., Wilson K.M., Xi Y., Horowitz M.C. Inflammation and bony changes at the temporomandibular joint. Cells Tissues Organs. 169:2001;257-264.